Literature DB >> 19572074

Immune versus thrombotic stimulation of platelets differentially regulates signalling pathways, intracellular protein-protein interactions, and alpha-granule release.

Sybille Rex1, Lea M Beaulieu, David H Perlman, Olga Vitseva, Price S Blair, Mark E McComb, Catherine E Costello, Jane E Freedman.   

Abstract

In addition to haemostasis, platelets mediate inflammation and clearance of bacteria from the bloodstream. As with platelet-platelet interactions, platelet-bacteria interactions involve cytoskeletal rearrangements and release of granular content. Stimulation of the immune Toll-like receptor 2 (TLR2) on the platelet surface, activates phosphoinositide-3-kinase (PI3K) and causes platelet activation and platelet-dependent thrombosis. It remains unknown if platelet activation by immune versus thrombotic pathways leads to the differential regulation of signal transduction, protein-protein interactions, and alpha-granule release, and the physiological relevance of these potential differences. We investigated these processes after immune versus thrombotic platelet stimulation. We examined selected signalling pathways and found that phosphorylation kinetics of Akt, ERK1/2 and p38 differed dramatically between agonists. Next, we investigated platelet protein-protein interactions by mass spectrometry (MS)-based proteomics specifically targeting cytosolic factor XIIIa (FXIIIa) because of its function as a cytoskeleton-crosslinking protein whose binding partners have limited characterisation. Four FXIIIa-binding proteins were identified, two of which are novel interactions: FXIIIa-focal adhesion kinase (FAK) and FXIIIa-gelsolin. The binding of FAK to FXIIIa was found to be altered differentially by immune versus thrombotic stimulation. Lastly, we studied the effect of thrombin versus Pam(3)CSK(4) stimulation on alpha-granule release and observed differential release patterns for selected granule proteins and decreased fibrin clot formation compared with thrombin. The inhibition of PI3K caused a decrease in protein release after Pam(3)CSK(4)- but not after thrombin-stimulation. In summary, stimulation of platelets by either thrombotic or immune receptors leads to markedly different signalling responses and granular protein release consistent with differential contribution to coagulation and thrombosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19572074      PMCID: PMC2774228          DOI: 10.1160/TH08-08-0513

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  47 in total

1.  Protransglutaminase (factor XIII) mediated crosslinking of fibrinogen and fibrin.

Authors:  K R Siebenlist; D A Meh; M W Mosesson
Journal:  Thromb Haemost       Date:  2001-11       Impact factor: 5.249

2.  Effects of ADP on different inhibitory properties of brain glutamate dehydrogenase isoproteins by perphenazine.

Authors:  H Y Yoon; S H Hwang; E Y Lee; T U Kim; E H Cho; S W Cho
Journal:  Biochimie       Date:  2001-09       Impact factor: 4.079

3.  Identification of the phosphotyrosine proteome from thrombin activated platelets.

Authors:  Patricia B Maguire; Kieran J Wynne; Donal F Harney; Niaobh M O'Donoghue; Gillian Stephens; Desmond J Fitzgerald
Journal:  Proteomics       Date:  2002-06       Impact factor: 3.984

4.  Molecular basis of platelet granule secretion.

Authors:  Robert Flaumenhaft
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-05-08       Impact factor: 8.311

Review 5.  Factor XIII subunit A as an intracellular transglutaminase.

Authors:  R Adány; H Bárdos
Journal:  Cell Mol Life Sci       Date:  2003-06       Impact factor: 9.261

6.  Demonstration of an activation regulated NF-kappaB/I-kappaBalpha complex in human platelets.

Authors:  Fengqi Liu; Steve Morris; Jerry Epps; Roger Carroll
Journal:  Thromb Res       Date:  2002-05-15       Impact factor: 3.944

7.  Involvement of proline-rich tyrosine kinase 2 in platelet activation: tyrosine phosphorylation mostly dependent on alphaIIbbeta3 integrin and protein kinase C, translocation to the cytoskeleton and association with Shc through Grb2.

Authors:  T Ohmori; Y Yatomi; N Asazuma; K Satoh; Y Ozaki
Journal:  Biochem J       Date:  2000-04-15       Impact factor: 3.857

8.  Platelet ERK2 activation by thrombin is dependent on calcium and conventional protein kinases C but not Raf-1 or B-Raf.

Authors:  Florence Nadal-Wollbold; Marc Pawlowski; Sylviane Lévy-Toledano; Eliane Berrou; Jean Philippe Rosa; Marijke Bryckaert
Journal:  FEBS Lett       Date:  2002-11-20       Impact factor: 4.124

9.  Stimulation of Toll-like receptor 2 in human platelets induces a thromboinflammatory response through activation of phosphoinositide 3-kinase.

Authors:  Price Blair; Sybille Rex; Olga Vitseva; Lea Beaulieu; Kahraman Tanriverdi; Subrata Chakrabarti; Chie Hayashi; Caroline A Genco; Mark Iafrati; Jane E Freedman
Journal:  Circ Res       Date:  2008-12-23       Impact factor: 17.367

Review 10.  The role of Toll-like receptor 2 in microbial disease and immunity.

Authors:  Lee M Wetzler
Journal:  Vaccine       Date:  2003-06-01       Impact factor: 3.641

View more
  34 in total

Review 1.  Platelets: versatile effector cells in hemostasis, inflammation, and the immune continuum.

Authors:  Adriana Vieira-de-Abreu; Robert A Campbell; Andrew S Weyrich; Guy A Zimmerman
Journal:  Semin Immunopathol       Date:  2011-08-06       Impact factor: 9.623

2.  Interleukin 1 receptor 1 and interleukin 1β regulate megakaryocyte maturation, platelet activation, and transcript profile during inflammation in mice and humans.

Authors:  Lea M Beaulieu; Elaine Lin; Eric Mick; Milka Koupenova; Ellen O Weinberg; Carolyn D Kramer; Caroline A Genco; Kahraman Tanriverdi; Martin G Larson; Emelia J Benjamin; Jane E Freedman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-01-23       Impact factor: 8.311

3.  Platelet-TLR7 mediates host survival and platelet count during viral infection in the absence of platelet-dependent thrombosis.

Authors:  Milka Koupenova; Olga Vitseva; Christopher R MacKay; Lea M Beaulieu; Emelia J Benjamin; Eric Mick; Evelyn A Kurt-Jones; Katya Ravid; Jane E Freedman
Journal:  Blood       Date:  2014-04-22       Impact factor: 22.113

Review 4.  Factor XIII is a key molecule at the intersection of coagulation and fibrinolysis as well as inflammation and infection control.

Authors:  Akitada Ichinose
Journal:  Int J Hematol       Date:  2012-04-05       Impact factor: 2.490

Review 5.  Platelets: at the nexus of antimicrobial defence.

Authors:  Michael R Yeaman
Journal:  Nat Rev Microbiol       Date:  2014-06       Impact factor: 60.633

Review 6.  Platelets in Pulmonary Immune Responses and Inflammatory Lung Diseases.

Authors:  Elizabeth A Middleton; Andrew S Weyrich; Guy A Zimmerman
Journal:  Physiol Rev       Date:  2016-08-03       Impact factor: 37.312

7.  Polyphosphate accelerates factor V activation by factor XIa.

Authors:  Sharon H Choi; Stephanie A Smith; James H Morrissey
Journal:  Thromb Haemost       Date:  2014-10-23       Impact factor: 5.249

8.  Oxidative Versus Thrombotic Stimulation of Platelets Differentially activates Signalling Pathways.

Authors:  Pouran Karimi; Nadereh Rashtchizadeh
Journal:  J Cardiovasc Thorac Res       Date:  2013-06-27

Review 9.  The role of inflammation in regulating platelet production and function: Toll-like receptors in platelets and megakaryocytes.

Authors:  Lea M Beaulieu; Jane E Freedman
Journal:  Thromb Res       Date:  2009-11-27       Impact factor: 3.944

Review 10.  Platelets as cellular effectors of inflammation in vascular diseases.

Authors:  Matthew T Rondina; Andrew S Weyrich; Guy A Zimmerman
Journal:  Circ Res       Date:  2013-05-24       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.